Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

For: Betori RC, Kallemeyn JM, Welch DS. A Kinetics-Based Approach for the Assignment of Reactivity Purge Factors. Org Process Res Dev 2015. [DOI: 10.1021/acs.oprd.5b00257] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]

For:	Betori RC, Kallemeyn JM, Welch DS. A Kinetics-Based Approach for the Assignment of Reactivity Purge Factors. Org Process Res Dev 2015. [DOI: 10.1021/acs.oprd.5b00257] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]

Number

Cited by Other Article(s)

Borths CJ, Argentine MD, Donaubauer J, Elliott EL, Evans J, Kramer TT, Lee H, Parsons R, Roberts JC, Sluggett GW, Teasdale A, Urquhart M, Wang K, Zhuang P. Control of Mutagenic Impurities: Survey of Pharmaceutical Company Practices and a Proposed Framework for Industry Alignment. Org Process Res Dev 2021. [DOI: 10.1021/acs.oprd.0c00517] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]

Burns MJ, Teasdale A, Elliott E, Barber CG. Controlling a Cohort: Use of Mirabilis-Based Purge Calculations to Understand Nitrosamine-Related Risk and Control Strategy Options. Org Process Res Dev 2020. [DOI: 10.1021/acs.oprd.0c00264] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]

Burns MJ, Ott MA, Teasdale A, Stalford SA, Antonucci V, Baumann JC, Brown R, Covey-Crump EM, Elder D, Elliott E, Fennell JW, Gallou F, Ide ND, Itoh T, Jordine G, Kallemeyn JM, Lauwers D, Looker AR, Lovelle LE, Molzahn R, Schils D, Schulte Oestrich R, Sluggett GW, Stevenson N, Talavera P, Urquhart MW, Varie DL, Welch DS. New Semi-Automated Computer-Based System for Assessing the Purge of Mutagenic Impurities. Org Process Res Dev 2019. [DOI: 10.1021/acs.oprd.9b00358] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]

Affiliation(s)

Michael J. Burns Lhasa Limited, Leeds LS11 5PS, West Yorskhire, U.K
Martin A. Ott Lhasa Limited, Leeds LS11 5PS, West Yorskhire, U.K
Andrew Teasdale AstraZeneca, Macclesfield SK10 4TG, Cheshire, U.K
Susanne A. Stalford Lhasa Limited, Leeds LS11 5PS, West Yorskhire, U.K
Vincent Antonucci Merck Sharp & Dohme Corporation, Rahway, New Jersey 07033, United States
Jens-Christoph Baumann F. Hoffmann-La Roche Limited, Basel CH-4070, Switzerland
Roland Brown Pfizer, Sandwich CT13 9ND, Kent, U.K
Elizabeth M. Covey-Crump Lhasa Limited, Leeds LS11 5PS, West Yorskhire, U.K
David Elder Consultant, Hertford SG14 2DE, Hertfordshire, U.K
Eric Elliott Takeda Pharmaceuticals, Cambridge, Massachusetts 02139, United States
Jared W. Fennell Eli Lilly and Company, Indianapolis, Indiana 46285, United States
Fabrice Gallou Novartis, Basel CH-4056, Switzerland
Nathan D. Ide AbbVie, North Chicago, Illinois 60064, United States
Tetsuji Itoh Merck Sharp & Dohme Corporation, Rahway, New Jersey 07033, United States
Guido Jordine Novartis, Basel CH-4056, Switzerland
Jeffrey M. Kallemeyn AbbVie, North Chicago, Illinois 60064, United States
Dirk Lauwers Janssen Pharmaceutica NV, Beerse 2340, Belgium
Adam R. Looker Vertex Pharmaceuticals, Boston, Massachusetts 02210, United States
Lucie E. Lovelle Novartis, Basel CH-4056, Switzerland
Robert Molzahn Excella GmbH & Company KG, Feucht 90537, Germany
Didier Schils Galapagos NV, Mechelen B-2800, Belgium
Rolf Schulte Oestrich F. Hoffmann-La Roche Limited, Basel CH-4070, Switzerland
Gregory W. Sluggett Pfizer, Groton 06340, Connecticut, United States
Neil Stevenson GlaxoSmithKline, Stevenage SG1 2NY, Hertfordshire, U.K
Pere Talavera Esteve Química, Barcelona 08030, Spain
Michael W. Urquhart GlaxoSmithKline, Stevenage SG1 2NY, Hertfordshire, U.K
David L. Varie Eli Lilly and Company, Indianapolis, Indiana 46285, United States
Dennie S. Welch AbbVie, North Chicago, Illinois 60064, United States

Collapse

Caspi DD, Nordstrom FL. Quantitative Impurity Rejection Analysis for Crystallization. Org Process Res Dev 2018. [DOI: 10.1021/acs.oprd.8b00143] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]

Teasdale A, Elder DP. Analytical control strategies for mutagenic impurities: Current challenges and future opportunities? Trends Analyt Chem 2018. [DOI: 10.1016/j.trac.2017.10.027] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/16/2022]

Teasdale A. Regulatory Highlights. Org Process Res Dev 2016. [DOI: 10.1021/acs.oprd.6b00087] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]